T-24 Retreatment with telaprevir/Peg-IFN/RBV after a short exposure to telaprevir in Phase I studies: interim results from a Phase IIIb rollover trial (C219)
G. Picchio, C. Sarrazin, H.W. Reesink, S. Zeuzem, C.J. Weegink, D. Luo, J. Witek, T.L. Kieffer, D. Bartels, I. Dierynck, S. De MeyerVolume:
44
Year:
2012
Language:
english
DOI:
10.1016/s1590-8658(12)60061-9
File:
PDF, 57 KB
english, 2012